Strenza Plus Kit
FDA Label NDC 73614-732

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Brisk Pharmaceuticals for the product Strenza Plus (NDC 73614-732). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Description

→ Package Label.principal Display Panel

Description

Rx Only

NDC 73614-732-03

For Use in Eyes Only

STRENZA Plus ™

Each Pack Contains:

Moxifloxacin Ophthalmic Solution, USP 0.5% - One 3 ml Bottle

Bromfenac Ophthalmic Solution 0.09% - One 1.7 ml Bottle

Prednisolone Acetate Ophthalmic Suspension, USP 1% - One 5 ml Bottle

Brisk Pharmaceuticals

Packaged by:

Unit Dose Solutions Inc.,

Morrisville, NC 27560

Distributed by:

Brisk pharmaceuticals,

Richardson, TX 75081

Keep out of reach of children.

TAMPER EVIDENT: Do not use the individual eye drops inside the pack if the seal on its bottle is broken or missing.

Lot: See the lot number on each individual bottle inside the pack.

Exp: See the expiration date on each individual bottle inside the pack.

* Please review the disclaimer below.

Previous Product 73614-731

Next Product 73614-922